|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,079,680 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,018,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 26 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-13 |
4 |
AS |
$93.42 |
$280,253 |
D/D |
(3,000) |
328,701 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-13 |
4 |
OE |
$14.39 |
$43,170 |
D/D |
3,000 |
331,701 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-15 |
4 |
OE |
$14.39 |
$57,560 |
D/D |
4,000 |
339,338 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-15 |
4 |
AS |
$94.40 |
$377,600 |
D/D |
(4,000) |
335,338 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-15 |
4 |
D |
$94.53 |
$2,660,358 |
D/D |
(28,143) |
300,558 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
34,780 |
335,338 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-19 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
336,338 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-22 |
4 |
D |
$88.05 |
$1,155,832 |
D/D |
(13,127) |
323,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-25 |
4 |
OE |
$14.39 |
$57,560 |
D/D |
4,000 |
327,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-25 |
4 |
AS |
$87.86 |
$351,440 |
D/D |
(4,000) |
323,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-27 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
324,211 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-03-29 |
4 |
A |
$86.01 |
$14,450 |
D/D |
168 |
7,064 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-05 |
4 |
OE |
$14.39 |
$43,170 |
D/D |
3,000 |
327,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-05 |
4 |
AS |
$93.37 |
$280,114 |
D/D |
(3,000) |
324,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-08 |
4 |
OE |
$14.39 |
$43,170 |
D/D |
3,000 |
327,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-08 |
4 |
AS |
$91.27 |
$275,598 |
D/D |
(3,000) |
324,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-11 |
4 |
OE |
$14.39 |
$14,390 |
D/D |
1,000 |
325,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-12 |
4 |
AS |
$89.12 |
$356,480 |
D/D |
(4,000) |
325,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-12 |
4 |
OE |
$14.39 |
$57,560 |
D/D |
4,000 |
329,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-16 |
4 |
OE |
$21.51 |
$21,510 |
D/D |
1,000 |
326,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-26 |
4 |
AS |
$82.44 |
$248,640 |
D/D |
(3,000) |
326,211 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,520 |
8,584 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-26 |
4 |
OE |
$14.39 |
$43,170 |
D/D |
3,000 |
329,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
326,520 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-05-08 |
4 |
AS |
$82.16 |
$328,625 |
D/D |
(4,000) |
326,520 |
0 |
- |
|
852 Records found
|
|
Page 26 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|